Cerner Enviza Collaborates with FDA to Develop Innovative AI Tools

 FDA's Sentinel Innovation Center chose Cerner Enviza and John Snow Labs for electronic health record and natural language processing expertise

 Cerner Enviza, an Oracle company, along with John Snow Labs, are now helping support the U.S. Food and Drug Administration's drug safety Sentinel Initiative. By developing artificial intelligence (AI) tools aimed at extracting critical information from clinical notes within electronic health records (EHR), Oracle and John Snow will aid the FDA in better understanding the effects of medicines on large populations. Looking at the asthma drug, montelukast, and its possibility of mental health side effects, this two-year project will demonstrate how the use of machine learning and natural language processing (NLP) technology with unstructured data may help fill gaps in knowledge.

https://finance.yahoo.com/news/cerner-enviza-collaborates-fda-develop-130000706.html